Glucocorticoid regulation of leptin synthesis and secretion in humans: Elevated plasma leptin levels in Cushing's syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 8, 1997, Pages 2542-2547

  Masuzaki, Hiroaki ^a   Ogawa, Yoshihiro ^a   Hosoda, Kiminori ^a   Miyawaki, Takashi ^a   Hanaoka, Ikuko ^a   Hiraoka, Junko ^a   Yasuno, Akiko ^a   Nishimura, Haruo ^a   Yoshimasa, Yasunao ^a   Nishi, Shigeo ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GLUCOCORTICOID; LEPTIN;

ADIPOSE TISSUE; ADRENAL CORTEX ADENOMA; ADULT; ARTICLE; BODY FAT; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; FEMALE; FOOD INTAKE; GENE EXPRESSION REGULATION; HUMAN; HYPOPHYSIS ADENOMA; MALE; OBESITY; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADENOMA; ADIPOSE TISSUE; ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; CUSHING SYNDROME; DEXAMETHASONE; FEMALE; GENE EXPRESSION; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; LEPTIN; MALE; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; PITUITARY NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEINS;

EID: 8544258847     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.8.2542     Document Type: Article

References (40)

1. Caro JF, Shinha MK, Kolaczynski JW, et al. 1996 Leptin: the tale of an obesity gone. Diabetes. 45:1455-1462.
2. Spiegelman BM, Flier JS. 1996 Adipogenesis and obesity: roundingout out the big picture. Cell. 87:377-389.
3. Zhang Y, Proenca P, Maffei M, Barone M, Leopold L, Friedman JM. 1994 Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425-432.
4. Tartaglia LA, Dembski M, Weng X, et al. 1995 Identification and expression cloning of a leptin receptor, OB-R. Cell. 83:1263-1271.
5. Ogawa Y, Masuzaki H, Isse N, et al. 1945 Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa] rats. J Clin Invest. 96:1647-1652.
6. Satoh N, Ogawa Y, Katsuura G, et al. 1997 Pathophysiologic significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. Endocrinology. 138:947-954.
7. Maffei M, Halaas J, Ravussin E, et al. 1995 Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1:155-1161.
8. Hosoda K, Masuzaki H, Ogawa Y, et al. 1996 Development of radioimmunoassay for human leptin. Biochem Biophys Res Commun. 221:234-239.
9. Considine RV, Sinha MK, Heiman ML, et al. 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 334:292-295.
10. Saladin R, de Vos P, Guerre-Millo M, et al. 1995 Transient increase in obese gene expression after food intake or insulin administration. Nature. 377:527-529.
11. Murakami T, Iida M, Shima K. 1995 Dexamethasone regulates obese expression in isolated rat adipocytes. Biochem Biophys Res Commun. 214:1260-1267.
12. De Vos P, Saladin R, Auwerx J, Staels B. 1995 Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem. 270:15958-15961.
13. Slieker LJ, Sloop KW, Surface PL, et al. 1996 Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem. 271:5301-5304.
14. Sainsbury A, Cusin I, Doyle P, et al. 1996 Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue. Diabetologia. 39:353-346.
15. s protein-coupled pathway in 3T3-L1 adipocytes. Diabetes. 45:1744-1749.
16. Zhang B, Graziano MP, Doebber TW, et al. 1996 Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J Biol Chem. 271:9455-9459.
17. Havel PJ, Kasim-Karakas S, Dubuc GR, Mueller W, Phinney SD. 1996 Gender differences in plasma Ieptin concentrations. Nat Med. 2:949-950.
18. Rosenbaum M, Nicolson M, Hirsch J, et al. 1996 Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab. 81:3424-3427.
19. Guillaume-Gentil C, Assimacopoulos-Jeannet F, Jeanrenaud B. 1993 Involvement of nonesterified fatty acid oxidation in glucocorticoids induced peripheral insulin resistance in vivo in rats. Diabetologia. 36:899-906.
20. Pagano G, Gavallo-Perin P, Cassader M, et al. 1983 An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest. 72:1814-1820.
21. Weinstein SP, Paquin T, Pritsker A, Haber RS. 1995 Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin and non-insulin-related stimuli. Diabetes. 44:441-445.
22. Tataranni PA, Ravussin E. 1995 Use of dual-energy x-ray absorptiometry in obese individuals. Am J Clin Nutr. 62:730-734.
23. Rebuffé-Scrive M, Krotkiewski M, Elfverson J, Björntorp P. 1988 Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J Clin Endocrinol Metab. 67:1122-1128.
24. Masuzaki H, Ogawa Y, Isse N, et al. 1995 Human obese gene expression: adipocyte-specific expression and regional differences in the adipose tissue. Diabetes. 44:855-858.
25. Snedecor GW, Cochran WG. 1989 Statistical methods, 8th ed. Ames: Iowa State University Press; 374-397.
26. Sinha MK, Ohannesian JP, Heiman ML, et al. 1996 Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest. 97:1344-1347.
27. Miell JP, Englaro P, Blum WF. 1996 Dexamethasone induces an acute and sustained rise in circulating leptin levels in normal human subjects. Horm Metab Res. 28:704-707.
28. Leal-Cerro A, Considine RV, Peino R, et al. 1996 Serum immunoreactive-leptin levels are increased in patients with Cushing's syndrome. Horm Metab Res. 28:711-713.
29. Mayo-Smith W, Hayes CW, Biller BMK, et al. 1989 Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology. 170:515-518.
30. Ahima RS, Prabakaran D, Mantzoros C, et al. 1996 Role of leptin in the neuroendocrine response to fasting. Nature. 382:250-252.
31. Heiman MI, Craft LS, Hsiung HM, Shoner B, Stephens T. The hypothalamic-pituitary-adrenal-adipose axis. Proc of the 10th Int Congr of Endocrinol. 1996; 63.
32. Stephens TW, Basinski M, Bristow PK, et al. 1995 The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 377:530-532.
33. Schwartz MW, Baskin DG, Bukowski TR, et al. 1996 Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropetide Y gene expression in ob/ob mice. Diabetes. 45:531-535.
34. Erickson JC, Hollopeter G, Palmiter PD. 1996 Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropetide Y. Science. 274:1704-1707.
35. Akabayashi A, Watanabe Y, Wahlestedt C, et al. 1994 Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomized rats. Brain Res. 665:201-202.
36. Papaspyou-Rao S, Schneider SH, Pedersen RN, et al. 1996 Dexamethasone regulates leptin expression in human adipose tissue in vivo. Obesity Res. 4(Suppl 1):26S.
37. Kiess W, Engiaro P, Hanitsch S, Rascher W, Attanasio A, Blum WF. 1996 High leptin concentrations in serum of very obese children are further stimulated by dexamethasone. Horm Metab Res. 28:708-710.
38. Wabitsch M, Jensen PB, Blum WF, et al. 1996 Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes. 45:1435-1438.
39. Considine RV, Nyce MR, Kolaczynski JW, et al. Insulin inhibits the dexamethasone stimulated increase in ob gene expression in human adipocytes. Proc of the 56th Annual Meet and Scientific Sessions of the Am Diabetes Assoc. 1996; 172A.
40. Gong D-W, Bi S, Pratley RE, Weitraub BD. 1996 Genomic structure and promoter analysis of the human obese gene. J Biol Chem. 271:3971-3974.